SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein

• Background:

  The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2) . A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

• Accession Number:

  QHD43416.1

• Tag:

  His-Avi

• Type:

  Recombinant Proteins

• Source:

  HEK293 cells

• Field of Research:

  Infectious Disease, COVID-19

• Buffer:

  20mM PB (pH 7.4) . 5 % trehalose is added as protectant before lyophilization.

• Shipping Conditions:

  Room Temp

• Storage Conditions:

  Store in working aliquots at -20˚ C. Avoid freeze/thaw cycles.

• Applications Notes:

  SDS-PAGE

• Other Product Names:

  S protein RBD, Spike glycoprotein Receptor-binding domain, S glycoprotein RBD, Spike protein RBD

• Tested Applications:

  ELISA, WB

• Species:

  SARS Spike Protein

• Physical Properties:

  Lyophilized

• CAS Number:

  9000-83-3